Curi RMB Capital’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14M | Buy |
118,654
+718
| +0.6% | +$100K | 0.25% | 103 |
|
|
2025
Q4 | $19.3M | Sell |
117,936
-4,373
| -4% | -$685K | 0.33% | 75 |
|
|
2025
Q3 | $16.3M | Buy |
122,309
+9,902
| +9% | +$1.2M | 0.3% | 90 |
|
|
2025
Q2 | $14M | Buy |
112,407
+1,199
| +1% | +$153K | 0.27% | 107 |
|
|
2025
Q1 | $14.2M | Sell |
111,208
-595
| -0.5% | -$91.6K | 0.35% | 88 |
|
|
2024
Q4 | $16.1M | Sell |
111,803
-1,409
| -1% | -$202K | 0.37% | 77 |
|
|
2024
Q3 | $16.8M | Buy |
113,212
+685
| +0.6% | +$98.2K | 0.38% | 76 |
|
|
2024
Q2 | $14.2M | Buy |
112,527
+967
| +0.9% | +$152K | 0.34% | 87 |
|
|
2024
Q1 | $20.5M | Buy |
111,560
+4,605
| +4% | +$877K | 0.47% | 68 |
|
|
2023
Q4 | $19.2M | Buy |
106,955
+547
| +0.5% | +$85.2K | 0.59% | 55 |
|
|
2023
Q3 | $16.9M | Buy |
106,408
+3,796
| +4% | +$621K | 0.58% | 59 |
|
|
2023
Q2 | $14.5M | Buy |
102,612
+1,834
| +2% | +$294K | 0.48% | 67 |
|
|
2023
Q1 | $17M | Buy |
100,778
+3,524
| +4% | +$629K | 0.59% | 54 |
|
|
2022
Q4 | $16.5M | Sell |
97,254
-11,282
| -10% | -$2.05M | 0.59% | 55 |
|
|
2022
Q3 | $20.3M | Sell |
108,536
-778
| -0.7% | -$164K | 0.76% | 39 |
|
|
2022
Q2 | $17.8M | Buy |
109,314
+4,611
| +4% | +$729K | 0.61% | 51 |
|
|
2022
Q1 | $19.7M | Buy |
104,703
+11,496
| +12% | +$2.18M | 0.62% | 52 |
|
|
2021
Q4 | $24.7M | Sell |
93,207
-3,418
| -4% | -$921K | 0.74% | 44 |
|
|
2021
Q3 | $27.9M | Sell |
96,625
-1,691
| -2% | -$434K | 0.92% | 30 |
|
|
2021
Q2 | $19.6M | Buy |
98,316
+2,193
| +2% | +$425K | 0.66% | 46 |
|
|
2021
Q1 | $18.7M | Buy |
96,123
+3,489
| +4% | +$715K | 0.69% | 44 |
|
|
2020
Q4 | $17.8M | Sell |
92,634
-11,269
| -11% | -$2.05M | 0.65% | 42 |
|
|
2020
Q3 | $15.3M | Buy |
103,903
+3,897
| +4% | +$557K | 0.66% | 36 |
|
|
2020
Q2 | $12.4M | Buy |
100,006
+1,547
| +2% | +$182K | 0.54% | 47 |
|
|
2020
Q1 | $9.51M | Buy |
98,459
+13,305
| +16% | +$1.28M | 0.45% | 62 |
|
|
2019
Q4 | $7.88M | Buy |
85,154
+795
| +0.9% | +$66.8K | 0.22% | 116 |
|
|
2019
Q3 | $6.47M | Buy |
84,359
+3,999
| +5% | +$350K | 0.17% | 142 |
|
|
2019
Q2 | $6.91M | Sell |
80,360
-25,248
| -24% | -$1.72M | 0.17% | 139 |
|
|
2019
Q1 | $6.24M | Buy |
105,608
+12,005
| +13% | +$690K | 0.16% | 161 |
|
|
2018
Q4 | $4.94M | Sell |
93,603
-11,074
| -11% | -$649K | 0.13% | 186 |
|
|
2018
Q3 | $5.8M | Sell |
104,677
-13,138
| -11% | -$677K | 0.14% | 183 |
|
|
2018
Q2 | $5.54M | Sell |
117,815
-56,383
| -32% | -$2.32M | 0.13% | 196 |
|
|
2018
Q1 | $6.3M | Sell |
174,198
-37,092
| -18% | -$1.3M | 0.16% | 177 |
|
|
2017
Q4 | $7.67M | Buy |
211,290
+810
| +0.4% | +$29.3K | 0.2% | 150 |
|
|
2017
Q3 | $8.07M | Buy |
210,480
+31,590
| +18% | +$1.32M | 0.21% | 153 |
|
|
2017
Q2 | $7.41M | Buy |
+178,890
| New | +$6.8M | 0.21% | 150 |
|
Other funds holding RGEN
UCFA
VCM
VPM
MC
Curi RMB Capital's RGEN Position: Q1 2026 in Review
Curi RMB Capital increased its Repligen (RGEN) stake by 0.61% in Q1 2026, buying an estimated $100K and bringing the position to 118,654 shares worth $14M. The position accounts for 0.25% of the portfolio, ranked #103.
Curi RMB Capital first reported a position in RGEN in Q2 2017 and has held it in 36 quarters since. The position peaked at $27.9M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Curi RMB Capital held 118,654 shares of Repligen worth $14M as of Q1 2026.
- Curi RMB Capital bought 718 Repligen shares in Q1 2026, an estimated $100K.
- Repligen made up 0.25% of Curi RMB Capital's portfolio in Q1 2026, its #103 holding.
- Curi RMB Capital first reported a position in Repligen in Q2 2017 and has held it in 36 quarters since.
- Curi RMB Capital's Repligen position peaked at $27.9M in Q3 2021.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Curi RMB Capital's 13F filing for Q1 2026, filed 15 May 2026.